Skip to content
Menu

NewAmsterdam Pharma Company N.V. NAMS

Full chart Compare
Set alert

Price alert · NAMS

All alert types
19.51 USD -0.23 (-1.17%)

Regular-session close

18.90 -0.61 -3.12%

After hours · Nov 19, 5:01 PM ET

19.30 Day range 20.36
17.90 52-week range 42.21
YTD
-44.38%
1 year
-49.48%

Revenue & Expenses

Revenue Profit Costs
Other Income$21.86MGross Profit$22.44MNet Loss$203.82MCost of Revenue$59.00KExpenses$248.13MSelling, General & Admin$106.30MResearch & Development$141.83MRevenue$22.50M

Latest period ending Dec 31, 2025 · select a line to chart its full history

NAMS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
22.50M45.56M14.09M102.69M0
22.50M45.56M14.09M102.69M0
-225.68M-176.29M-182.97M-3.56M-29.84M
-203.82M-241.60M-176.94M-22.63M-28.60M
-1.72-2.56-2.15-1.19-1.21
NAMS annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
491.32M771.74M340.45M438.52M53.09M
769.28M864.62M347.10M531.58M59.78M
85.85M107.12M58.70M47.06M9.99M
202.00K448.00K60.00K118.00K164.00K
683.43M757.50M288.39M484.52M49.79M
NAMS annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-147.78M-158.56M-141.22M10.66M-25.16M
-174.92M-62.85M-24.00K-221.00K-20.00K
29.52M659.51M8.91M391.90M68.99M
-246.00K-672.00K-24.00K-221.00K-20.00K
-293.18M438.10M-132.33M402.35M43.81M